CAD 0.03
(0.0%)
Year | Eps | Eps Growth |
---|---|---|
2022 | -0.06 CAD | -82.85% |
2021 | -0.03 CAD | -209.0% |
2020 | -0.01 CAD | 0.0% |
2019 | -0.01 CAD | 75.0% |
2018 | -0.04 CAD | 0.0% |
Year | Eps | Eps Growth |
---|---|---|
2023 Q3 | -0.00 CAD | 39.02% |
2023 Q2 | -0.00 CAD | 6.82% |
2023 Q1 | -0.00 CAD | 0.0% |
2022 Q1 | -0.01 CAD | -385.71% |
2022 FY | - CAD | -82.85% |
2022 Q4 | - CAD | 100.0% |
2022 Q3 | -0.01 CAD | -12.73% |
2022 Q2 | -0.01 CAD | 46.08% |
2021 Q4 | -0.00 CAD | 0.0% |
2021 Q2 | -0.01 CAD | -66.67% |
2021 Q3 | - CAD | 100.0% |
2021 FY | - CAD | -209.0% |
2021 Q1 | -0.01 CAD | -27.66% |
2020 FY | - CAD | 0.0% |
2020 Q4 | -0.00 CAD | 0.0% |
2020 Q3 | - CAD | 100.0% |
2020 Q2 | -0.00 CAD | 28.57% |
2020 Q1 | -0.00 CAD | -3.7% |
2019 Q1 | -0.00 CAD | 45.16% |
2019 FY | - CAD | 75.0% |
2019 Q4 | -0.00 CAD | 0.0% |
2019 Q3 | - CAD | 100.0% |
2019 Q2 | -0.00 CAD | -47.06% |
2018 FY | - CAD | 0.0% |
2018 Q4 | -0.00 CAD | 0.0% |
2018 Q3 | - CAD | 100.0% |
2018 Q1 | -0.02 CAD | -100.0% |
2018 Q2 | -0.01 CAD | 50.0% |
2017 Q4 | -0.01 CAD | 0.0% |
Name | Eps | Eps Difference |
---|---|---|
Arch Biopartners Inc. | -0.05 CAD | -6.004% |
Covalon Technologies Ltd. | -0.18 CAD | 68.611% |
Hemostemix Inc. | -0.03 CAD | -86.469% |
Kane Biotech Inc. | -0.04 CAD | -57.382% |
MedMira Inc. | -0.00 CAD | -1386.842% |
Marvel Biosciences Corp. | -0.06 CAD | 2.249% |
NervGen Pharma Corp. | -0.38 CAD | 85.132% |
XORTX Therapeutics Inc. | -1.44 CAD | 96.076% |